Jay L.

Jay L. has a diverse range of work experience, primarily in the fields of biotech, life sciences, and venture capital. Starting in 2020, Jay has been an investor through Bonaventure Equity, LLC, supporting companies such as FloraWorks, Sensorium Therapeutics, Nalu Bio, and tCheck. In 2021, Jay joined the board of directors at Pebble Life Science and AcquiFlow, LLC. In 2022, Jay also took on advisory roles at FloraWorks and Earnd. In 2023, Jay became an advisor at AIM7 Inc. and Surf Synergy. Throughout their career, Jay has been focused on investing in cannabinoid and psychedelic innovations, supporting scientific breakthroughs, and commercializing ventures in the healthcare industry.

Jay L. attended Stanford University from 1987 to 1991 and obtained a Bachelor's degree in Economics. Following their undergraduate studies, they pursued a Master's in Business at the Olin Business School of Washington University in St. Louis from 1991 to 1993.